Tang WZ, Xu WZ, Liu TH. Re: Ugradar et al.: Rate of re-treatment in patients treated with teprotumumab: a multicenter study of 119 patients with 1 year of follow-up (Ophthalmology. 2025;132:92-97). Ophthalmology 2025 Jan 16:S0161-6420(24)00758.
PMID: 39818625